Literature DB >> 1423591

A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors.

Y Luo1, H Fujii, T Gerster, R G Roeder.   

Abstract

A novel B cell-restricted activity, required for high levels of octamer/Oct-dependent transcription from an immunoglobulin heavy chain (IgH) promoter, was detected in an in vitro system consisting of HeLa cell-derived extracts complemented with fractionated B cell nuclear proteins. The factor responsible for this activity was designated Oct coactivator from B cells (OCA-B). OCA-B stimulates the transcription from an IgH promoter in conjunction with either Oct-1 or Oct-2 but shows no significant effect on the octamer/Oct-dependent transcription of the ubiquitously expressed histone H2B promoter and the transcription of USF- and Sp1-regulated promoters. Taken together, our results suggest that OCA-B is a tissue-, promoter-, and factor-specific coactivator and that OCA-B may be a major determinant for B cell-specific activation of immunoglobulin promoters. In light of the evidence showing physical and functional interactions between Oct factors and OCA-B, we propose a mechanism of action for OCA-B and discuss the implications of OCA-B for the transcriptional regulation of other tissue-specific promoters.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1423591     DOI: 10.1016/0092-8674(92)90352-d

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  92 in total

1.  UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions.

Authors:  H Ge
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Crystal structure of an OCA-B peptide bound to an Oct-1 POU domain/octamer DNA complex: specific recognition of a protein-DNA interface.

Authors:  D Chasman; K Cepek; P A Sharp; C O Pabo
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

3.  Activator recruitment by the general transcription machinery: X-ray structural analysis of the Oct-1 POU domain/human U1 octamer/SNAP190 peptide ternary complex.

Authors:  Stacy Hovde; Craig S Hinkley; Katie Strong; Aimee Brooks; Liping Gu; R William Henry; James Geiger
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

4.  Identification of transcription coactivator OCA-B-dependent genes involved in antigen-dependent B cell differentiation by cDNA array analyses.

Authors:  Unkyu Kim; Rachael Siegel; Xiaodi Ren; Cary S Gunther; Terry Gaasterland; Robert G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

5.  Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer.

Authors:  L Dailey; H Yuan; C Basilico
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  Cloning and functional characterization of LCR-F1: a bZIP transcription factor that activates erythroid-specific, human globin gene expression.

Authors:  J J Caterina; D Donze; C W Sun; D J Ciavatta; T M Townes
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

7.  Characterization of constitutive HSF2 DNA-binding activity in mouse embryonal carcinoma cells.

Authors:  S P Murphy; J J Gorzowski; K D Sarge; B Phillips
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

8.  A cell-specific factor represses stimulation of transcription in vitro by transcriptional enhancer factor 1.

Authors:  S Chaudhary; C Brou; M E Valentin; N Burton; L Tora; P Chambon; I Davidson
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

9.  Two different IFN-gamma nonresponsive variants derived from the B-cell lymphoma 70Z/3.

Authors:  L D Rhodes; A T Paull; C H Sibley
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

10.  Discovery platform for inhibitors of IgH gene enhancer activity.

Authors:  Nathan G Dolloff
Journal:  Cancer Biol Ther       Date:  2018-11-27       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.